Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The company was founded in 2007 and is headquartered in Bundoora, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.02
Trade Value (12mth)
AU$1,696.00
1 week
0%
1 month
-33.33%
YTD
-86.77%
1 year
-90.84%
All time high
0.32
EPS 3 yr Growth
-54.50%
EBITDA Margin
N/A
Operating Cashflow
-$5m
Free Cash Flow Return
-261.00%
ROIC
-267.00%
Interest Coverage
-60.90
Quick Ratio
2.40
Shares on Issue (Fully Dilluted)
726m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
30 June 25 |
Board Change
×
Board Change |
13 June 25 |
Renounceable Rights Issue shortfall placed
×
Renounceable Rights Issue shortfall placed |
13 June 25 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
13 June 25 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
13 June 25 |
Change in Director Interest Notice (IR & DF)
×
Change in Director Interest Notice (IR & DF) |
11 June 25 |
Change in Director Interest Notice (TO, PM, IR & DF)
×
Change in Director Interest Notice (TO, PM, IR & DF) |
05 June 25 |
Change in substantial holding
×
Change in substantial holding |
04 June 25 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
04 June 25 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
04 June 25 |
Top 20 Option Holders & Distribution Schedule
×
Top 20 Option Holders & Distribution Schedule |
03 June 25 |
Rights Issue raises $1.1million
×
Rights Issue raises $1.1million |
28 May 25 |
Notice of change of exercise price of options
×
Notice of change of exercise price of options |
22 May 25 |
New AD-214 publication
×
New AD-214 publication |
19 May 25 |
Investor webinar invitation
×
Investor webinar invitation |
07 May 25 |
COMMENCEMENT OF RIGHTS TRADING
×
COMMENCEMENT OF RIGHTS TRADING |
07 May 25 |
Investor Presentation
×
Investor Presentation |
05 May 25 |
Prospectus
×
Prospectus |
05 May 25 |
Update - Proposed issue of securities - 1AD
×
Update - Proposed issue of securities - 1AD |
05 May 25 |
Target Market Determination
×
Target Market Determination |
05 May 25 |
Letter to Optionholders
×
Letter to Optionholders |
05 May 25 |
Letter to Foreign Shareholders
×
Letter to Foreign Shareholders |
05 May 25 |
Update - Proposed issue of securities - 1AD
×
Update - Proposed issue of securities - 1AD |
02 May 25 |
Change of registered address
×
Change of registered address |
01 May 25 |
Quarterly Appendix 4C and Activities Report
×
Quarterly Appendix 4C and Activities Report |
01 May 25 |
Renounceable Rights Issue to Raise up to $1.3 million
×
Renounceable Rights Issue to Raise up to $1.3 million |
01 May 25 |
Proposed issue of securities - 1AD
×
Proposed issue of securities - 1AD |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.